Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood test device put to the test for accuracy

NCT ID NCT07307352

Diagnosis Sponsor: Radiometer Medical ApS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked how precisely a blood gas analyzer (ABL90 FLEX PLUS) measures 15 different things in tiny blood samples from adults. 39 adults gave blood samples at two sites in Denmark. The goal was to see if the device gives consistent results when used by different people in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

39 people

The number who actually took part.

Started

Jan 2026

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years old ) admitted to the hospital with low (moderate hypo), normal, or elevated (moderate hyper) concentrations of the 15 parameters covering the reportable range as much as possible.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The subject must be 18 years or older. * Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study. * Subject evaluated as suitable according to the protocol to enroll in the study by the principal investigator or designee Exclusion Criteria: * Subject where sample collection is evaluated by principal investigator or designee to impose an unnecessary risk. * Subject, with known pregnancy or breastfeeding. * Subject, who has an invalid written informed consent or has withdrawn consent. * Subjects who have been previously enrolled in the study. * Subjects exposed to following substances within the last 72 hours: * Acetylsalicylic Acid Sodium Salt at dose equal or above 1 gram/day * N-acetylcysteine o Fluorescein dye o Patent Blue dye -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diagnostic tests are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diagnostic tests

Contacts and locations

Locations

  • Hvidovre Hospital

    Hvidovre, 2650, Denmark

  • Sjællands Universitets Hospital Køge

    Køge, 4600, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.